Skip to content
6-K

Foreign Interim / Material

China SXT Pharmaceuticals, Inc. SXTC

0001013762-25-003583

← back to feed
Filed
Mar 28, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Stock Issued Q2 2025 · Sep 30, 2024 1.69M sh
Stock Issued Q2 2025 · Oct 5, 2023 20 sh
Stock Issued Q2 2025 · May 19, 2022 20 sh
Stock Issued Q2 2025 · Feb 22, 2021 20 sh
Shares Diluted Q2 2025 · Sep 30, 2024 3.23M sh
Shares Diluted Q2 2025 · Sep 30, 2023 501.47K sh
Operating Cash Flow Q2 2025 · Sep 30, 2024 −$1.36M
Operating Cash Flow Q2 2025 · Sep 30, 2023 −$579.57K
Long Term Debt Q2 2025 · Sep 30, 2024 $115.34K
Long Term Debt Q2 2025 · Mar 31, 2024 $117.13K
Short Term Debt Q2 2025 · Sep 30, 2024 $827.92K
Short Term Debt Q2 2025 · Mar 31, 2024 $493.05K
Cash And Equivalents Q2 2025 · Sep 30, 2024 $18.51M
Cash And Equivalents Q2 2025 · Mar 31, 2024 $12.07M
Stockholders Equity Q2 2025 · Sep 30, 2024 $15.03M
Stockholders Equity Q2 2025 · Mar 31, 2024 $13.93M
Stockholders Equity Q2 2025 · Sep 30, 2023 $5.08M
Stockholders Equity Q2 2025 · Mar 31, 2023 $14.69M
Current Liabilities Q2 2025 · Sep 30, 2024 $15.66M
Current Liabilities Q2 2025 · Mar 31, 2024 $8.9M
Total Liabilities Q2 2025 · Sep 30, 2024 $15.96M
Total Liabilities Q2 2025 · Mar 31, 2024 $9.2M
Current Assets Q2 2025 · Sep 30, 2024 $21.99M
Current Assets Q2 2025 · Mar 31, 2024 $14.23M
Total Assets Q2 2025 · Sep 30, 2024 $31M
Total Assets Q2 2025 · Mar 31, 2024 $23.13M
Eps Diluted Q2 2025 · Sep 30, 2024 −$0.25
Eps Diluted Q2 2025 · Sep 30, 2023 −$19.34
Eps Basic Q2 2025 · Sep 30, 2024 −$0.25
Eps Basic Q2 2025 · Sep 30, 2023 −$19.34
Sga Expense Q2 2025 · Sep 30, 2024 $722.4K
Sga Expense Q2 2025 · Sep 30, 2023 $9.46M
Net Income Q2 2025 · Sep 30, 2024 −$802.57K
Net Income Q2 2025 · Sep 30, 2023 −$9.7M
Operating Income Q2 2025 · Sep 30, 2024 −$638.27K
Operating Income Q2 2025 · Sep 30, 2023 −$9.35M
Gross Profit Q2 2025 · Sep 30, 2024 $134.75K
Gross Profit Q2 2025 · Sep 30, 2023 $288.34K
Cost Of Revenue Q2 2025 · Sep 30, 2024 $694.74K
Cost Of Revenue Q2 2025 · Sep 30, 2023 $651.24K
Revenue Q2 2025 · Sep 30, 2024 $829.49K
Revenue Q2 2025 · Sep 30, 2023 $939.58K